Aralez Bio

Berkeley, United States · $12.0M raised

Employees
1–10
Business Model
B2B
Total Funding
$12.0M
Last Round
$12.0M Series AOct 2024
Rounds
2

About

Aralez Bio is a Berkeley, California-based biotechnology platform company that harnesses engineered enzymes and directed evolution to manufacture noncanonical amino acids (ncAAs) for use in peptide therapeutics and sustainable chemical production. The company’s proprietary enzymatic approach enables high-purity, cost-effective, and scalable synthesis of specialty amino acids that were previously difficult or expensive to produce, replacing traditional multi-step chemical synthesis with greener biocatalytic processes. Aralez Bio operates a manufacturing plant in Berkeley and serves pharmaceutical and biotech customers seeking faster, more sustainable raw material supply chains.

Summary

Aralez Bio is a Biotech company based in Berkeley, United States. It has raised $12.0M in total across 2 rounds, most recently a $12.0M Series A round in Oct 2024. Investors include Paladin Capital Group, Fifty Years and Good Growth Capital.

Sign up to view the funding chart

Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AOct 2024
$12.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies